Literature DB >> 10416407

Total hip arthroplasty after failed intertrochanteric valgus osteotomy for advanced osteoarthrosis.

T Iwase1, Y Hasegawa, S Iwasada, S Kitamura, H Iwata.   

Abstract

Thirty hips that had undergone conversion total hip arthroplasty because of failed intertrochanteric valgus osteotomy for advanced osteoarthrosis were analyzed clinically and radiographically for more than 2 years. The average followup after total hip arthroplasty was 7 years (range, 2-18 years). The average age of the patients at the time of valgus osteotomy was 42 years (range, 30-63 years). The average age of the patients at the time of conversion total hip arthroplasty was 57 years (range, 43-76 years), and the average period between valgus osteotomy and conversion was 14 years (range, 3-24 years). Perioperative complications in conversion total hip arthroplasties were minimal, and intramedullary reaming was performed easily. Of the 30 conversion total hip arthroplasties, 12 cemented and 18 cementless components were used, respectively. Kaplan-Meier's survival analysis indicated that survivorship of cemented stems was significantly higher than that of conventional cementless stems. Cemented stems are preferable for conversion total hip arthroplasty after failed femoral valgus osteotomy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10416407     DOI: 10.1097/00003086-199907000-00023

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  10 in total

1.  Cemented total hip arthroplasty with retention of some existing hardware.

Authors:  Fernando Monteiro Judas; Joana Bento Rodrigues; Francisco Manuel Lucas; João Paulo Freitas
Journal:  BMJ Case Rep       Date:  2014-07-02

Review 2.  [Hip arthroplasty in the presence of proximal femoral deformity].

Authors:  A Rakow; P Simon; C Perka
Journal:  Orthopade       Date:  2015-07       Impact factor: 1.087

3.  Long-term results of cementless femoral reconstruction following intertrochanteric osteotomy.

Authors:  Christian Merle; Marcus R Streit; Moritz Innmann; Tobias Gotterbarm; Peter R Aldinger
Journal:  Int Orthop       Date:  2012-01-12       Impact factor: 3.075

4.  Similar clinical outcomes for THAs with and without prior periacetabular osteotomy.

Authors:  Derek F Amanatullah; Louis Stryker; Perry Schoenecker; Michael J Taunton; John C Clohisy; Robert T Trousdale; Rafael J Sierra
Journal:  Clin Orthop Relat Res       Date:  2014-10-31       Impact factor: 4.176

5.  What Is the Impact of a Previous Femoral Osteotomy on THA? A Systematic Review.

Authors:  Enrico Gallazzi; Ilaria Morelli; Giuseppe Peretti; Luigi Zagra
Journal:  Clin Orthop Relat Res       Date:  2019-05       Impact factor: 4.176

6.  Management of femoral neck fracture non union with modified Pauwels' osteotomy.

Authors:  N K Magu; Om Lahoti
Journal:  J Clin Orthop Trauma       Date:  2021-12-03

7.  Cementless total hip arthroplasty for patients previously treated with femoral osteotomy for hip dysplasia: the incidence of periprosthetic fracture.

Authors:  Masanobu Ohishi; Yasuharu Nakashima; Takuaki Yamamoto; Goro Motomura; Jun-Ichi Fukushi; Satoshi Hamai; Yusuke Kohno; Yukihide Iwamoto
Journal:  Int Orthop       Date:  2015-09-19       Impact factor: 3.075

8.  Experience of valgus osteotomy for neglected and failed osteosynthesis in fractures neck of femur.

Authors:  Jatin Prakash; Vikas Keshari; Rajesh Kumar Chopra
Journal:  Int Orthop       Date:  2019-10-24       Impact factor: 3.075

9.  Unstable recent intracapsular femoral neck fractures in young adults: osteosynthesis and primary valgus osteotomy using broad dynamic compression plate.

Authors:  M P Singh; Aditya N Aggarwal; Anil Arora; Ish K Dhammi; Jagjit Singh
Journal:  Indian J Orthop       Date:  2008-01       Impact factor: 1.251

10.  Modular stem in total hip arthroplasty for patients with trochanter valgus deformity: surgical technique and case series.

Authors:  Xiangpeng Kong; Wei Chai; Minzhi Yang; Alvin Ong; Jiying Chen; Yan Wang; Yonggang Zhou
Journal:  BMC Musculoskelet Disord       Date:  2020-02-24       Impact factor: 2.362

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.